EBS Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 1.90%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $29,526.50

Emergent BioSolutions Insider Trading History Chart

Emergent BioSolutions Share Price & Price History

^$2.39

▲ +0.25 (11.68%)

As of 12/1/2023 01:00 AM ET

Days: 30 | 90 | 365

Trading Experts Call It “The Perfect Tesla Trade”

From Wealthpress | Ad

Click here for details,

Emergent BioSolutions Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
6/2/2023	Kathryn C Zoon	Director	Sell	1,830	$8.35	$15,280.50	49,971
5/25/2023	Kathryn C Zoon	Director	Sell	1,700	$8.38	$14,246.00	51,801
11/25/2022	Ronald Richard	Director	Sell	1,912	$11.94	$22,829.28	19,837
6/9/2022	Kathryn C Zoon	Director	Sell	1,173	$31.52	$36,972.96	19,654
5/24/2022	Kathryn C Zoon	Director	Sell	1,996	$35.53	$70,917.88	12,381
11/15/2021	Richard S. Lindahl	CFO	Buy	3,000	$37.46	$112,380.00
5/25/2021	Kathryn C Zoon	Director	Sell	3,139	$56.48	$177,290.72	14,377
3/4/2021	Sue Bailey	Director	Sell	8,168	$92.37	$754,478.16	24,427
1/21/2021	Robert Kramer	CEO	Sell	21,900	$110.03	$2,409,657.00	141,442
1/15/2021	Robert Kramer	CEO	Sell	19,026	$106.01	$2,016,946.26

New CBOE “special perk” helps traders target income every weekend

From DTI Trader | Ad

You might not immediately realize what you’re reading. Let me help you out a little… What you're looking at is a “special perk” set up by the Chicago Board of Options Exchange.

Check out this training for the full story!

SEC Filings (Institutional Ownership Changes) for Emergent BioSolutions (NYSE:EBS)

88.26% of Emergent BioSolutions stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Emergent BioSolutions Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/30/2023	American Century Companies Inc.	299,643	$1.02M	0.0%	-17.9%	0.578%
11/24/2023	Deutsche Bank AG	24,260	$82K	0.0%	-90.9%	0.047%
11/22/2023	Graham Capital Management L.P.	12,651	$43K	0.0%	N/A	0.024%
11/17/2023	Jacobs Levy Equity Management Inc.	1,246,020	$4.24M	0.0%	+0.9%	2.405%
11/16/2023	Tudor Investment Corp Et Al	22,383	$76K	0.0%	N/A	0.043%
11/16/2023	Wolverine Trading LLC	23,915	$81K	0.0%	+231.4%	0.046%
11/15/2023	Sei Investments Co.	96,310	$0.33M	0.0%	+121.9%	0.186%
11/15/2023	Laurion Capital Management LP	11,012	$37K	0.0%	N/A	0.021%
11/15/2023	Legal & General Group Plc	30,243	$0.10M	0.0%	-88.8%	0.058%
11/15/2023	AQR Capital Management LLC	179,118	$0.61M	0.0%	+73.7%	0.346%
11/14/2023	Lazard Asset Management LLC	26,782	$91K	0.0%	N/A	0.052%
11/14/2023	Gotham Asset Management LLC	10,797	$37K	0.0%	N/A	0.021%
11/14/2023	Sherbrooke Park Advisers LLC	41,417	$0.14M	0.0%	N/A	0.080%
11/14/2023	California State Teachers Retirement System	51,263	$0.17M	0.0%	-9.6%	0.099%
11/14/2023	Prescott Group Capital Management L.L.C.	299,187	$1.02M	0.2%	-2.5%	0.577%
11/13/2023	Connor Clark & Lunn Investment Management Ltd.	209,534	$0.71M	0.0%	N/A	0.404%
11/13/2023	Northern Trust Corp	488,353	$1.66M	0.0%	-8.4%	0.943%
11/13/2023	Federated Hermes Inc.	204,829	$0.70M	0.0%	-18.6%	0.395%
11/13/2023	Acadian Asset Management LLC	73,363	$0.25M	0.0%	N/A	0.142%
11/13/2023	Hsbc Holdings PLC	75,133	$0.25M	0.0%	+295.4%	0.145%
11/13/2023	Invesco Ltd.	302,985	$1.03M	0.0%	-61.6%	0.585%
11/13/2023	FMR LLC	127,484	$0.43M	0.0%	+84.6%	0.246%
11/13/2023	Envestnet Asset Management Inc.	23,533	$80K	0.0%	N/A	0.045%
11/9/2023	Rhumbline Advisers	83,136	$0.28M	0.0%	-48.3%	0.160%
11/9/2023	Deutsche Bank AG	24,260	$82K	0.0%	-90.9%	0.047%
11/9/2023	Citigroup Inc.	15,068	$51K	0.0%	-92.2%	0.029%
11/9/2023	UBS Group AG	89,167	$0.30M	0.0%	-57.4%	0.172%
11/8/2023	Shell Asset Management Co.	46,970	$0.16M	0.0%	+757.6%	0.091%
11/8/2023	Charles Schwab Investment Management Inc.	1,561,050	$5.31M	0.0%	+44.8%	3.013%
11/8/2023	Values First Advisors Inc.	152,699	$0.52M	0.3%	+200.0%	0.295%
11/8/2023	New York Life Investment Management LLC	34,367	$0.12M	0.0%	-13.6%	0.066%
11/7/2023	Quantbot Technologies LP	8,700	$30K	0.0%	+218.7%	0.017%
11/7/2023	Barclays PLC	113,404	$0.39M	0.0%	-60.0%	0.219%
11/6/2023	Assenagon Asset Management S.A.	182,892	$0.62M	0.0%	+92.0%	0.353%
11/6/2023	Los Angeles Capital Management LLC	172,715	$0.59M	0.0%	+92.5%	0.333%
11/2/2023	Principal Financial Group Inc.	39,288	$0.13M	0.0%	-85.9%	0.076%
10/27/2023	Allspring Global Investments Holdings LLC	453,565	$1.54M	0.0%	+51.3%	0.875%
10/26/2023	Mirae Asset Global Investments Co. Ltd.	22,389	$76K	0.0%	-47.0%	0.043%
10/24/2023	Bank of New York Mellon Corp	239,358	$0.81M	0.0%	-50.5%	0.462%
10/13/2023	SG Americas Securities LLC	24,299	$83K	0.0%	N/A	0.047%
9/21/2023	Barclays PLC	283,407	$2.08M	0.0%	+80.5%	0.547%
8/21/2023	Osaic Holdings Inc.	5,667	$42K	0.0%	+139.5%	0.011%
8/16/2023	Nuveen Asset Management LLC	56,201	$0.41M	0.0%	-59.0%	0.108%
8/15/2023	Wells Fargo & Company MN	127,635	$0.94M	0.0%	+41.2%	0.246%
8/15/2023	XTX Topco Ltd	13,826	$0.10M	0.0%	N/A	0.027%
8/15/2023	Goldman Sachs Group Inc.	670,450	$4.93M	0.0%	-25.6%	1.294%
8/15/2023	Caxton Associates LP	50,265	$0.37M	0.1%	-32.9%	0.097%
8/15/2023	Royal Bank of Canada	115,355	$0.85M	0.0%	+391.9%	0.223%
8/14/2023	Tower Research Capital LLC TRC	15,542	$0.11M	0.0%	+73.7%	0.030%
8/14/2023	Marshall Wace LLP	185,564	$1.36M	0.0%	+1,468.3%	0.358%
8/14/2023	State of Wisconsin Investment Board	95,180	$0.70M	0.0%	-14.8%	0.184%
8/14/2023	State Street Corp	6,794,144	$49.94M	0.0%	+25.7%	13.114%
8/14/2023	Jefferies Financial Group Inc.	60,000	$0.44M	0.0%	N/A	0.116%
8/14/2023	Capital Fund Management S.A.	91,917	$0.68M	0.0%	N/A	0.177%
8/14/2023	Palisade Capital Management LP	538,418	$3.96M	0.1%	+4.8%	1.039%
8/14/2023	Nuveen Asset Management LLC	56,201	$0.41M	0.0%	-59.0%	0.108%
8/11/2023	Boulder Hill Capital Management LP	23,000	$0.17M	0.3%	-43.3%	0.046%
8/11/2023	Baird Financial Group Inc.	12,357	$91K	0.0%	N/A	0.024%
8/11/2023	Credit Suisse AG	73,090	$0.54M	0.0%	+94.9%	0.145%
8/11/2023	BlackRock Inc.	9,231,728	$67.85M	0.0%	-0.3%	18.299%
8/11/2023	Hotchkis & Wiley Capital Management LLC	1,134,420	$8.34M	0.0%	+20.2%	2.249%
8/11/2023	Campbell & CO Investment Adviser LLC	16,272	$0.12M	0.0%	N/A	0.032%
8/11/2023	AXQ Capital LP	10,100	$74K	0.1%	-54.4%	0.020%
8/11/2023	Hsbc Holdings PLC	19,004	$0.14M	0.0%	-10.1%	0.038%
8/11/2023	Guggenheim Capital LLC	13,247	$97K	0.0%	-26.3%	0.026%
8/11/2023	Geode Capital Management LLC	924,484	$6.80M	0.0%	+3.1%	1.832%
8/11/2023	Sei Investments Co.	43,410	$0.32M	0.0%	+18.5%	0.086%
8/11/2023	E Fund Management Co. Ltd.	31,274	$0.23M	0.0%	+43.8%	0.062%
8/11/2023	JPMorgan Chase & Co.	43,340	$0.32M	0.0%	-38.1%	0.086%
8/11/2023	PNC Financial Services Group Inc.	6,641	$49K	0.0%	+68.0%	0.013%
8/11/2023	Northern Trust Corp	533,095	$3.92M	0.0%	-0.4%	1.057%
8/10/2023	Prescott Group Capital Management L.L.C.	306,838	$2.26M	0.5%	N/A	0.608%
8/10/2023	Osaic Holdings Inc.	5,667	$42K	0.0%	+139.5%	0.011%
8/10/2023	Great West Life Assurance Co. Can	63,739	$0.47M	0.0%	-5.4%	0.126%
8/10/2023	Profund Advisors LLC	106,196	$0.78M	0.0%	+45.9%	0.210%
8/10/2023	Mirae Asset Global Investments Co. Ltd.	42,283	$0.32M	0.0%	+14.9%	0.084%
8/10/2023	Russell Investments Group Ltd.	157,114	$1.16M	0.0%	+1.3%	0.311%
8/10/2023	Jupiter Asset Management Ltd.	103,410	$0.76M	0.0%	-70.4%	0.205%
8/10/2023	Cetera Advisors LLC	61,338	$0.45M	0.0%	+463.7%	0.122%
8/10/2023	Charles Schwab Investment Management Inc.	1,078,418	$7.93M	0.0%	+31.3%	2.138%
8/10/2023	Citigroup Inc.	193,990	$1.43M	0.0%	-40.7%	0.385%
8/9/2023	Dimensional Fund Advisors LP	1,489,585	$10.95M	0.0%	-17.7%	2.953%
8/9/2023	BNP Paribas Arbitrage SNC	118,980	$0.88M	0.0%	-29.3%	0.236%
8/9/2023	Swiss National Bank	98,700	$0.73M	0.0%	+1.9%	0.196%
8/9/2023	Commonwealth of Pennsylvania Public School Empls Retrmt SYS	50,752	$0.37M	0.0%	+8.0%	0.101%
8/8/2023	Rhumbline Advisers	160,762	$1.18M	0.0%	+1.5%	0.319%
8/7/2023	Principal Financial Group Inc.	279,319	$2.05M	0.0%	-4.2%	0.554%
8/7/2023	New York Life Investment Management LLC	39,781	$0.29M	0.0%	-21.3%	0.079%
8/3/2023	Los Angeles Capital Management LLC	89,719	$0.66M	0.0%	+101.8%	0.178%
8/3/2023	Barclays PLC	283,407	$2.08M	0.0%	+80.5%	0.562%
8/3/2023	Bank of New York Mellon Corp	483,577	$3.55M	0.0%	-4.1%	0.959%
8/2/2023	LSV Asset Management	40,700	$0.30M	0.0%	-42.9%	0.081%
7/31/2023	Inspire Investing LLC	42,564	$0.31M	0.0%	+63.0%	0.084%
7/28/2023	Shell Asset Management Co.	5,477	$40K	0.0%	-33.3%	0.011%
7/25/2023	Assenagon Asset Management S.A.	95,238	$0.70M	0.0%	N/A	0.189%
7/24/2023	Allspring Global Investments Holdings LLC	299,715	$2.20M	0.0%	+2,347.1%	0.594%
7/24/2023	SummerHaven Investment Management LLC	15,285	$0.11M	0.1%	-43.4%	0.030%
7/19/2023	Teacher Retirement System of Texas	12,304	$90K	0.0%	-11.0%	0.024%
7/18/2023	Louisiana State Employees Retirement System	23,600	$0.17M	0.0%	+14.0%	0.047%
7/18/2023	Allspring Global Investments Holdings LLC	299,715	$2.20M	0.0%	+2,347.1%	0.594%

Data available starting January 2016

Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. Its products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emerging infectious diseases; travel health; public health crises; and acute, emergency, and community care. The company offers ACAM2000, a smallpox vaccine; Anthrasil to for inhalational anthrax; Botulism Antitoxin Heptavalent to treat botulinum disease; BioThrax, an anthrax vaccine; Ebanga, a monoclonal antibody to treat infection caused by Zaire ebolavirus; raxibacumab injection for the treatment of inhalational anthrax; reactive skin decontamination lotion kits; TEMBEXA for the treatment of human smallpox disease; Trobigard, an auto-injector atropine sulfate and obidoxime chloride auto-injector for the emergency treatment of known or suspected exposure to nerve agents; and vaccinia immune globulin intravenous that addresses complications from smallpox vaccine. It also provides NARCAN, a nasal spray for the emergency treatment of known or suspected opioid overdose; Vivotif, an oral vaccine for typhoid fever; and Vaxchora, a single-dose oral vaccine to treat cholera. In addition, the company is developing AV7909, an anthrax vaccine; CGRD-001, a pralidoxime chloride/atropine auto-injector; CHIKV VLP, a chikungunya virus VLP vaccine; EBS-LASV; EGRD-001, a diazepam auto-injector; SIAN, an antidote for the initial treatment of acute poisoning of cyanide; and UniFlu, a universal influenza vaccine. Further, it provides contract development and manufacturing services comprising drug substance and product manufacturing, and packaging, as well as technology transfer, process, and analytical development services. The company was incorporated in 1998 and is headquartered in Gaithersburg, Maryland.

Today's Range

Now: $2.39

$2.01

$2.46

50 Day Range

MA: $2.43

$1.82

$3.40

52 Week Range

Now: $2.39

$1.81

$16.66

Volume

2,159,500 shs

Average Volume

1,736,221 shs

Market Capitalization

$123.82 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.02

Who are the company insiders with the largest holdings of Emergent BioSolutions?: Emergent BioSolutions' top insider investors include:
Kathryn C Zoon (Director)
Ronald Richard (Director)
Learn More about top insider investors at Emergent BioSolutions.
Who are the major institutional investors of Emergent BioSolutions?: Emergent BioSolutions' top institutional shareholders include:
Charles Schwab Investment Management Inc. — 3.01%
Jacobs Levy Equity Management Inc. — 2.41%
Northern Trust Corp — 0.94%
Allspring Global Investments Holdings LLC — 0.88%
Invesco Ltd. — 0.58%
American Century Companies Inc. — 0.58%
Learn More about top institutional investors of Emergent BioSolutions stock.
Which institutional investors are selling Emergent BioSolutions stock?: In the last quarter, EBS stock was sold by these institutional investors:
Invesco Ltd.
Bank of New York Mellon Corp
Deutsche Bank AG
Deutsche Bank AG
Principal Financial Group Inc.
Legal & General Group Plc
Citigroup Inc.
Barclays PLC
Which institutional investors are buying Emergent BioSolutions stock?: During the last quarter, EBS stock was acquired by institutional investors including:
Charles Schwab Investment Management Inc.
Connor Clark & Lunn Investment Management Ltd.
Allspring Global Investments Holdings LLC
Values First Advisors Inc.
Assenagon Asset Management S.A.
Los Angeles Capital Management LLC
AQR Capital Management LLC
Acadian Asset Management LLC